ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging)

ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging)
复制标题

DOI:
10.1161/01.cir.0000080946.42225.4d
复制
发表时间:
2003-09-16
期刊:
影响因子:
37.8
通讯作者:
Russell, RO
Russell, RO
中科院分区:
医学1区
文献类型:
--
作者:
Klocke, FJ;Baird, MG;Russell, RO

文献摘要

被引文献

相似文献

美国心脏病学会(ACC)/美国心脏协会(AHA)实践指南工作组定期审查现有指南,以确定何时需要更新或全面修订。心脏放射性核素成像临床应用指南最初于1986年出版,并于1995年更新。自1995年以来,特别是在急性和慢性局部缺血综合症和心力衰竭领域,继续出现重要的新发展。因此,工作组认为应该重新讨论该主题,并邀请美国核心脏病学会(ASNC)共同赞助这项工作,这是三个组织的共同努力。指引全文可于互联网上查阅(www. acc.org,www.美国心脏。org和www. asnc。org)。它讨论了核心脏病学技术在3个广泛领域的有用性:急性缺血综合征,慢性综合征和心力衰竭。考虑了诊断、疾病严重程度/风险评估/预后和治疗评估的效用。附录中提供了各种技术的描述。本执行摘要包括使用特定技术的推荐适应症和对全文文件中所述主题的总结评价。全文文件中提供了其他支持性证据和完整的参考文献列表。目前的指南与以前发表的几个ACC/AHA指南重叠,用于可能涉及心脏放射性核素成像的患者治疗。这些包括已发表的慢性稳定型心绞痛(SA; 2002)、不稳定型心绞痛和非ST段抬高型心肌梗死(UA/NSTEMI; 2002)、心力衰竭(2001)、非心脏手术围手术期心血管评价(2002)、运动试验(2002)、心脏瓣膜病(1998)和急性心肌梗死(AMI; 1999)指南。本报告不打算列入这些准则以前涵盖的资料,也不打算全面论述这些准则所涉的专题。ACC/AHA分类I、II和III用于将适应症总结如下:I类:有证据和/或普遍认为给定程序或治疗有用且有效的疾病II类:关于程序或治疗的有用性/有效性存在相互矛盾的证据和/或意见分歧的疾病
The American College of Cardiology (ACC)/American Heart Association (AHA) Task Force on Practice Guidelines regularly reviews existing guidelines to determine when an update or full revision is needed. Guidelines for the Clinical Use of Cardiac Radionuclide Imaging were originally published in 1986 and updated in 1995. Important new developments have continued to occur since 1995, particularly in the areas of acute and chronic ischemic syndromes and heart failure. The Task Force therefore believed the topic should be revisited de novo and invited the American Society for Nuclear Cardiology (ASNC) to cosponsor the undertaking, which represents a joint effort of the 3 organizations. The full-text guideline is available on the Internet (www. acc. org, www. americanheart. org, and www. asnc. org). It discusses the usefulness of nuclear cardiological techniques in 3 broad areas: acute ischemic syndromes, chronic syndromes, and heart failure. Utility is considered for diagnosis, severity of disease/risk assessment/prognosis, and assessment of therapy. An appendix provides descriptions of individual techniques. This Executive Summary includes recommended indications for the use of specific techniques and summary evaluations of topics addressed in the full-text document. Additional supporting evidence and a complete reference list are presented in the full-text document. The current guideline overlaps with several previously published ACC/AHA guidelines for patient treatment that potentially involve cardiac radionuclide imaging. These include published guidelines for chronic stable angina (SA; 2002), unstable angina and non–ST-elevation myocardial infarction (UA/NSTEMI; 2002), heart failure (2001), perioperative cardiovascular evaluation for noncardiac surgery (2002), exercise testing (2002), valvular heart disease (1998), and acute myocardial infarction (AMI; 1999). The present report is not intended to include information previously covered in these guidelines or to provide a comprehensive treatment of the topics addressed in these guidelines. The ACC/AHA classifications I, II, and III are used to summarize indications as follows:Class I: Conditions for which there is evidence and/or general agreement that a given procedure or treatment is useful and effective Class II: Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment